Schedule at a Glance

Media | Gallery | Contact

Home / 2022 SABCS^® / 2022 SABCS Program / Schedule at a Glance

Schedule at a Glance

Daily Schedule:

Poster Sessions:

Spotlight Sessions:

Schedule at a Glance

TO VIEW THE FULL SCHEDULE SEE THE DAILY SCHEDULE AND SESSIONS LIST
Tuesday, December 6, 2022 All times are CENTRAL Time
8:00 am - 9:45 am CT	Clinical Research Workshop - Stars at Night Ballroom 1&2 Moderator: Aditya Bardia, MD, MPH Massachusetts General Hospital Boston, MA Use of the postneoadjuvant setting to accelerate drug development Melinda Telli, MD Stanford University School of Medicine Stanford, CA How to measure and improve drug adherence in clinical trials Dawn L. Hershman, MD, MS Columbia University Medical Center New York, NY Statistical considerations for precision medicine Nabihah Tayob, PhD Dana-Farber Cancer Institute Boston, MA Bringing trials to all patients: A patient's perspective Thelma Perry Brown, BSc University of Alabama at Birmingham Birmingham, AL
8:00 am - 9:45 am CT	Basic Science Workshop - Stars at Night Ballroom 3&4 Moderator: Alana L. Welm, PhD University of Utah Salt Lake City, UT Drug-tolerant persister cells in cancer Joan S. Brugge, PhD Harvard Medical School Boston, MA APOBEC and genome evolution in mBC Reuben S. Harris, PhD UT Health San Antonio San Antonio, TX Therapy-induced senescence: Friend or foe? Sheila Stewart, PhD Washington University St. Louis, MO Clinical implications of tumor heterogeneity single cell genomics Nnennaya Kanu, PhD University College London, Cancer Institute London, United Kingdom
9:45 am - 10:00 am CT	Break
10:00 am - 12:00 pm CT	EDUCATIONAL SESSION BLOCK #1
	EDUCATIONAL SESSION BLOCK #1A - Stars at Night Ballroom 3&4 Living with Metastatic Breast Cancer Moderator: Anne Blaes, MD, MSc University of Minnesota Minneapolis, MN Early palliative care Tara L. Kaufmann, MD, MSCE Dell Medical School University Of Texas at Austin Austin, TX Support for patients with MBC Abbey Kaler, NP UT MD Anderson Cancer Center Houston, TX Financial Toxicity Fumiko Chino, MD Memorial Sloan Kettering Cancer Center New York, NY Patient Perspective Christine Hodgdon, MS GRASP - Guiding Researchers & Advocates to Scientific Partnerships Baltimore, MD Stephanie Walker, BSN MBC Alliance Tarboro, NC EDUCATIONAL SESSION BLOCK #1B - Hemisfair Ballroom 1&2 Local Therapy - Best Breast Practice Moderator: Peter Dubsky, MD, PhD Breast Center Hirslanden Klinik St. Anna Luzem, Switzerland Contralateral mastectomy in patients with germline mutations Katharine A. Yao, MD Northshore University HealthSystem Evanston, IL RT: How short can it be David Krug, Dr Med Universitätsklinikum Schleswig-Holstein Kiel, Germany How to reconcile novel reconstructive techniques with the need to radiate Christine Solbach, MD, PhD University Hospital Frankfurt Frankfurt, Germany EDUCATIONAL SESSION BLOCK #1C - Hemisfair Ballroom 3 New Agents Targeting HRD in Breast Cancer Moderator: Erica Stringer-Reasor, MD University of Alabama at Birmingham Birmingham, AL Pol-theta inhibitors in HRD tumors Alan D. d'Andrea, MD Dana-Farber Cancer Institute Boston, MA Mechanisms of sensitivity and resistance to HRD targeting agents in breast cancer - PARPi and beyond Christopher Lord, DPhil Institute of Cancer Research London, United Kingdom ATR inhibitors and PARP1 selective PARP inhibitors Andrew Tutt, MB ChB, PhD Institute of Cancer Research London, United Kingdom EDUCATIONAL SESSION BLOCK #1D - Stars at Night Ballroom 1&2 Predictive Value of Treatment Response and Residual Disease After Neoadjuvant Therapy Moderator: Virginia G. Kaklamani, MD UT Health San Antonio San Antonio, TX Hormone receptor positive breast cancer Cynthia X. Ma, MD, PhD Washington University in St. Louis St. Louis, MO HER2 positive breast cancer Luca Gianni, MD Fondazione Michelangelo Milano, Italy Triple negative breast cancer Peter Schmid, MD, PhD, FRCP Bart's Cancer Institute London, United Kingdom
12:00 pm - 2:00 pm CT	SPECIAL SESSION #1 - Stars at Night Ballroom 1&2 Big Data and Health Equity Moderators: Thelma Brown, BSc University of Alabama at Birmingham Birmingham, AL Maimah Karmo, BS Tigerlily Foundation Aldie, VA Charles Perou, PhD University of North Carolina Chapel Hill, NC Keynote Speakers: Martin Mendoza, PhD National Institutes of Health Bethesda, MD Barbara Seggara, D.H.Sc University of Puerto Rico San Juan, Puerto Rico Panelists: Rea Blakey FDA Silver Spring, MD Thelma Perry Brown, BSc University of Alabama at Birmingham Birmingham, AL Andrea Downing The Light Collective Shoreline, WA Michael Crawford, MBA, MHLA Howard University Washington, DC Erika Hamilton, MD Sarah Cannon Research Institute Nashville, TN Martin Mendoza, PhD National Institute of Health Bethesda, MD Charlotte Owens, MD Takeda Pharmaceutical Company Cambridge, MA Barbara Seggara, D.H.Sc University of Puerto Rico San Juan, Puerto Rico Jasmine Souers, BSc The Missing Pink Breast Cancer Alliance Jackson, FL SPECIAL SESSION #2 - Hall 3 Overcoming the Big Obstacles to Find Solutions for Breast Cancer Chairs: Carlos Arteaga, MD UT Southwestern Medical Center Simmons Comprehensive Cancer Center Dallas, TX and Angela DeMichele, MD, MSCE University of Pennsylvania Abramson Cancer Center Philadelphia, PA Panelists: Christine Ambrosone, PhD Roswell Park Comprehensive Cancer Center Buffalo, NY Fabrice André, MD, PhD Gustave Gustave Roussy Villejuif, France Regina Barzilay, PhD Massachusetts Institute of Technology Cambridge, MA Joan S. Brugge, PhD Harvard Ludwig Cancer Center Boston, MA Matthew J. Ellis, MD, PhD AstraZeneca Washington, DC Nadia Harbeck, MD, PhD LMU University Hospital Munich, Germany Yeon Hee Park, MD, PhD Samsung Medical Center Seoul, South Korea Lori Pierce, MD University of Michigan Ann Arbor, MI Patty Spears, BS University of North Carolina at Chapel Hill Chapel Hill, NC Eric Winer, MD Yale Cancer Center New Haven, CT
2:00 pm - 5:00 pm CT	GENERAL SESSION #1 - Hall 3
5:00 pm - 6:15 pm	POSTER SESSION #1 - Hall 1
5:00 pm - 6:15 pm	SPOTLIGHT POSTER DISCUSSION SESSION #1 Racial Outcomes and Disparities - Hemisfair Ballroom 1&2 SPOTLIGHT POSTER DISCUSSION SESSION #2 Tumor Immunology and Novel Immune Therapy Strategies - Stars at Night Ballroom 1&2 SPOTLIGHT POSTER DISCUSSION SESSION #3 New Radiation Techniques - Stars at Night Ballroom 3&4
	OPEN SATELLITE EVENTS - Marriott Rivercenter
7:00 pm - 9:00 pm	Clarifying the Complexities and Augmenting the Options in the Treatment of HR+/HER2- Breast Cancer: How to Build Better Skills to Make the Most of Existing and Emerging Therapies for the Benefit of Patients With HR+/HER2- MBC and EBC presented by PVI, PeerView Institute for Medical Education
7:00 pm	Expanding the Spectrum of HER2-Positivity for Precision Breast Cancer Care:Clinical Implications of HER2-Low Status presented by Clinical Care Options,LLC
7:00 pm	Medical Crossfire®: Clinical Decision Making Under New Paradigms for HR+/HER2-Breast Cancer presented by Physicians' Education Resource, LLC

Wednesday, December 7
7:00 am - 8:15 am	POSTER SESSION #2 - Hall 1
7:00 am - 8:15 am	SPOTLIGHT POSTER DISCUSSION SESSION #4 Single Cell Approaches for Translational Research and Biomarker Discovery - Hemisfair Ballroom 1&2 SPOTLIGHT POSTER DISCUSSION SESSION #5 Advances in TNBC Biology - Stars at Night Ballroom 3&4 SPOTLIGHT POSTER DISCUSSION SESSION #6 Special Populations: Male Breast Cancer/Geriatrics - Stars at Night Ballroom 1&2
8:30 am - 9:00 am	WILLIAM L. MCGUIRE MEMORIAL LECTURE - Hall 3 Leveraging Preclinical Models for Translational Breast Cancer Research Jeffrey Rosen, PhD Baylor College of Medicine Houston, TX
9:00 am - 9:45 am CT	GENERAL SESSION #2 - Hall 3
9:45 am - 11:00 am CT	HER2 Low: A Separate Entity? Special Session - Hall 3 Chairs: Adam Brufsky, MD, PhD University of Pittsburgh Pittsburgh, PA and Kalliopi Siziopikou, MD, PhD Northwestern University Chicago, IL PRO Giuseppe Curigliano, MD, PhD IEO Istituto Europeo di Oncologia Milano, Italy Con Sara Tolaney, MD Dana-Farber Cancer Institute Boston, MA
10:00 am - 5:00 pm CT	EXHIBITS - Hall 2
11:00 am - 12:00 pm CT	MINI-SYMPOSIUM #1 - Hall 3 C. Kent Osborne HER2 and ER Crosstalk: Signaling Mechanisms and Clinical Implications Symposium Moderator: Carlos Arteaga, MD UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center Dallas, TX and Virginia G. Kaklamani, MD UT Health San Antonio San Antonio, TX Special Guest: C. Kent Osborne, MD Baylor College of Medicine Houston, TX Oncogene signal transduction and antiestrogen resistance Rachel Schiff, PhD Baylor College of Medicine Houston, TX HER2 signaling the ER cistrome Rinath Jeselsohn, MD Dana-Farber Cancer Institute Boston, M Treatment of ER+/HER2+ breast cancer Stephen Johnston, MBBS The Royal Marsden Hospital London, United Kingdom
12:00 PM - 12:30 PM	PLENARY LECTURE #1 - Hall 3 Lineage-defined Metabolism of Normal Mammary Cells and Origins of Cancer Metabolic Heterogeneity Rama Khokha, PhD University Health Network Toronto, Canada
12:30 pm - 1:00 pm	AACR DISTINGUISHED LECTURESHIP IN BREAST CANCER RESEARCH, supported by Aflac Inc. - Hall 3 Quantitative Medicine for Breast Cancer Patients Charles M. Perou, PhD University of North Carolina at Chapel Hill Chapel Hill, NC
12:30 pm - 1:30 pm CT	CAREER DEVELOPMENT FORUM - Room 304
1:00 pm - 2:00 pm CT	CLINICAL CASE DISCUSSION SESSION - Stars at Night Ballroom 1&2 Moderator: Mothaffar Rimawi, MD Baylor College of Medicine Houston, TX Panelist: Michael Gnant, MD, FACS, FEBShon Medical University of Vienna Vienna, Austria Celina Kleer, MD University of Michigan Medical School Ann Arbor, MI Julia Maues GRASP Washington, DC George Sledge, Jr, MD Stanford University Stanford, CA Jonathan Strauss, MD Northwestern Chicago, IL
1:00 pm - 2:00 pm CT	FORUM #1 - Stars at Night Ballroom 3&4 Molecular Aspects of DCIS Progression Moderator: E. Shelley Hwang, MD, MPH Duke University Durham, NC Tumor stroma in DCIS progression Robert West, MD, PhD Stanford University Medical Center Stanford, CA Clonal evolution of DCIS to invasion Jelle Wesseling, MD, PhD Netherlands Cancer Institute Amsterdam, Netherlands Defining clinical risk: How do we tailor therapy Kimberly J. Van Zee, MS, MD, FACS Memorial Sloan Kettering Cancer Center New York, NY
2:00 pm - 3:00 pm CT	CLINICAL CONTROVERSIES - Hall 3 Moderator: Lisa Carey, MD, ScM, FASCO UNC-Lineberger Comprehensive Cancer Center Chapel Hill, NC To clip or not to clip Abigail Caudle, MD UT MD Anderson Cancer Center Houston, TX and Viviana E. Galimberti, MD, MPH European Institute of Oncology Milan, Italy Duration of endocrine therapy Kathryn Ruddy, MD, PhD Mayo Clinic Rochester, MN and Eleftherios (Terry) Mamounas, MD, MSc Orlando Health Cancer Institute Orlando, FL Post Neoadjuvant therapy in TNBC Heather McArthur, MD, MPH UT Southwestern Dallas, TX and Susan Domchek, MD University of Pennsylvania School of Medicine Philadelphia, PA
2:00 pm - 3:00 pm CT	MINI-SYMPOSIUM #2 - Stars at Night Ballroom 1&2 Late Recurrence and Tumor Dormancy Moderator: Alana Welm, PhD Masonic Cancer Center University of Minnesota Minneapolis, MN NK cells and dormancy Isaac Chan, MD UT Southwestern Medical Center Dallas, TX Extra cellular matrix and dormancy Javier Bravo-Cordero, PhD Icahn School of Medicine New York, NY Implications for clinical care Alexandra Thomas, MD, FACP Wake Forest Baptist Health Winston-Salem, NC
2:00 pm - 3:00 pm CT	FORUM #2 New Targets and Strategies for Immunotherapy - Stars at Night Ballroom 3&4 Moderator: Justin Balko, PhD Vanderbilt University Medical Center Nashville, TN Activating a collaborative innate-adaptive immune response to control metastasis Mikala Egeblad, PhD Cold Spring Harbor Laboratory Cold Spring Harbor, NY Neutrophil elastase and anti-tumor effects Lev Becker, PhD University of Chicago Chicago, IL Immunosuppressive macrophages and PARP inhibitor resistance Jennifer Guerriero, PhD Brigham and Women's Hospital Boston, MA
3:00 pm - 5:00 pm CT	EDUCATIONAL SESSION BLOCK #2 EDUCATIONAL SESSION BLOCK #2A - Hemisfair Ballroom 1&2 Digital Health and PROs in Breast Cancer Research and Care Moderator: Ann H. Partridge, MD, MPH Dana Farber Institute Boston, MA What are PROs and evidence for benefit? Shoshana Rosenberg, ScD, MPH Weill Cornell Medicine New York, NY How to incorporate PROs into clinical care Oluwadamilola "Lola" Fayanju, MD, MA, MPHS, FACS Perelman School of Medicine at the University of Pennsylvania Philadelphia, PA Where are we going with digital interventions and PROs Ines Vaz Luis, PhD Gustave Roussy Villejuif, France Patient Advocate Perspective Patty Spears, BS UNC Patient Advocates for Research Council Chapel Hill, NC EDUCATIONAL SESSION BLOCK #2B - Stars at Night Ballroom 1&2 Antibody Drug Conjugates: Future Directions and Opportunities Moderator: Ian E. Krop, MD, PhD Yale School of Medicine New Haven, CT Bioengineering and mechanism of action of ADC Puja Sapra, PhD AstraZeneca New York, NY ADCs in breast oncology: Present and future Shanu Modi, MD Memorial Sloan Kettering Cancer Center New York, NY Mechanisms of resistance Leif Ellisen, MD, PhD Massachusetts General Hospital Boston, MA EDUCATIONAL SESSION BLOCK #2C - Stars at Night Ballroom 3&4 Spatial and Single Cell Characterization of Breast Cancer - Progression Moderator: Christina Curtis, PhD, MSc Stanford University School of Medicine Stanford, CA Single cell profiling Alex Swarbrick, PhD Garvan Institute of Medical Research Darlinghurst, Australia Multiplex spatial proteomic profiling David Rimm, MD, PhD Yale University New Haven, CT Imaging mass cytometry of breast cancer Raza Ali, MD, FRCPC, MSc Cancer Research UK Cambridge Institute Cambridge, United Kingdom Beyond the lab: Clinical implications Christina Curtis, PhD, MSc Stanford University School of Medicine Stanford, CA EDUCATIONAL SESSION BLOCK #2D - Hemisfair Ballroom 3 Breast Cancer and Cardiovascular Toxicity: What an Oncologist Needs to Know Moderators: Carmen Bergom, MD, PhD Washington University in St. Louis St. Louis, MO and Susan Dent, MD Duke Durham, NC Beyond anthracyclines and trastuzumab: Cardiotoxicity of new novel agents Susan Dent, MD Duke Durham, NC Radiation therapy and cardiovascular disease in breast cancer Carmen Bergom, MD, PhD Washington University in St. Louis St. Louis, MO Cardiovascular toxicity and breast cancer: Detection and prevention strategies Dinesh Thavendiranathan, MD, MSc Peter Munk Cardiac Center, Toronto General Hospital, University of Toronto Toronto, Canada Perspective 1: Cardiac problems secondary to chemotherapy Kiran Dhillon, PhD UW Medicine Seattle, WA Perspective 2: Cardiac problems secondary to chemotherapy Alexea Gaffney Adams, Dr. Med Alexea Gaffney-Adams New York, NY
5:00 pm - 6:15 pm CT	POSTER SESSION #3 - Hall 1
5:00 pm - 6:15 pm CT	SPOTLIGHT POSTER DISCUSSION SESSION #7 - Brain Metastasis - Stars at Night Ballroom 3&4 SPOTLIGHT POSTER DISCUSSION SESSION #8 - Symptom Management and Associated Toxicities - Stars at Night Ballroom 1&2 SPOTLIGHT POSTER DISCUSSION SESSION #9 - Immune Landscape and Microenvironments - Hemisfair Ballroom 1&2
	OPEN SATELLITE EVENTS - Marriott Rivercenter
7:00 pm	Precision Medicine Advances in Early Breast Cancer: Experts Discuss the Expanding Role of Biomarkers to Guide Neo/Adjuvant Therapy presented by Clinical Care Options, LLC
7:15 pm - 9:15 pm	What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of HER2-Positive Breast Cancer — An Independent Satellite Symposium Held in Conjunction with the 45th Annual San Antonio Breast Cancer Symposium presented by Research to Practice
Thursday, December 8
7:00 am - 8:15 am CT	POSTER SESSION #4 - Hall 1
7:00 am - 8:15 am CT	SPOTLIGHT POSTER DISCUSSION SESSION #10 Endocrine Therapy and Resistance - Stars at Night Ballroom 3&4 SPOTLIGHT POSTER DISCUSSION SESSION #11 Improving Outcome for TNBC: New Directions in Immunotherapy - Stars at Night Ballroom 1&2 SPOTLIGHT POSTER DISCUSSION SESSION #12 Obesity and Breast Cancer- Hemisfair Ballroom 1&2
8:30 am - 11:00 am CT	GENERAL SESSION #3 - Hall 3
10:00 am - 5:00 pm CT	EXHIBITS - Hall 2
11:00 am - 12:00 pm CT	DEBATE Are all of CDK4/6 Inhibitors the Same or Different?- Hall 3
12:00 pm - 12:30 pm CT	PLENARY LECTURE #2 - Hall 3 Premenopausal ER+ Breast Cancer: Past, Present, and Future Prudence Francis, MD Peter MacCullum Cancer Centre Victoria, Australia
12:30 pm - 1:00 pm CT	BRINKER AWARD FOR SCIENTIFIC DISTINCTION IN BASIC SCIENCE Guardian at the Gates: Genome Stability, Cell State, Plasticity, and Breast Cancer Geoffrey M. Wahl, PhD Salk Institute for Biological Studies La Jolla, CA
1:00 pm - 2:00 pm CT	MOLECULAR TUMOR BOARD - Stars at Night Ballroom 1&2 Moderator: Giuseppe Curigliano, MD, PhD European Institute of Oncology Milano, Italy Panelist: Philippe Bedard, MD Princess Margaret Cancer Centre Toronto, Canada Amy L. Delson University of California San Francisco Atherton, CA Erika Hamilton, MD Sarah Cannon Research Institute Nashville, TN Sara Hurvitz, MD, FACP University of California San Francisco Los Angeles, CA Antonio Marra, MD Memorial Sloan Kettering Cancer Center New York, NY Aleix Prat, MD, PhD Hospital Clinic Barcelona Barcelona, Spain Daniel Stover, MD Ohio State University Comprehensive Cancer Center Columbus, OH
1:00 pm - 2:00 pm CT	FORUM #3 - Stars at Night Ballroom 3&4 Modifying Tumor Response: Microbiome, Diet, and Fasting Moderator: Sangeetha Reddy, MD, MSc UT Southwestern Medical Center Dallas, TX Fungal regulation of breast tumor radiation response Stephen L. Shiao, MD, PhD Cedars-Sinai Los Angeles, CA Microbiome and response to immunotherapy Jennifer A. Wargo, MD UT MD Anderson Cancer Center Houston, TX Fasting and Microbiotic Guido Kroemer, MD, PhD, PU-PH University of Paris Descartes Paris, France
2:00 pm - 3:00 pm CT	TRANSLATIONAL CONTROVERSIES - Stars at Night Ballroom 1&2 Moderator: Komal Jhaveri, MD, FACP Memorial Sloan Kettering Cancer Center New York, NY RIP MTD Hope S. Rugo, MD, FASCO University of California San Francisco San Francisco, CA Geoffrey Shapiro, MD, PhD Dana-Farber Cancer Institute Boston, MA Randomized trials vs real world evidence Angela DeMichele, MD, MSCE University of Pennsylvania Philadelphia, PA Sean Khozin, MD, MPH CancerLinQ, LLC New York, NY Ki 67 Nadia Harbeck, MD, PhD LMU University Hospital Munich, Germany Torsten Nielsen, MD, PhD, FRCPC University of British Columbia Vancouver, Canada
2:00 pm - 3:00 pm CT	FORUM #4 - Stars at Night Ballroom 3&4 Demystifying CDKs in Breast Cancer: Beyond CDK4/6 Moderator: Rinath Jeselsohn, MD Dana-Farber Cancer Institute Boston, MA CDK4/6 inhibitor resistance: Biological mechanisms and novel approaches Ariella Hanker, PhD UT Southwestern Medical Center Dallas, TX Current status of CDK2 inhibitors in (pre-)clinical development Sarat Chandarlapaty, MD, PhD Memorial Sloan Kettering Cancer Center New York, NY Inhibiting transcriptional CDKs in breast cancer Charles Coombes, MD, PhD Imperial College London, United Kingdom
3:00 pm - 5:00 pm CT	EDUCATIONAL SESSION BLOCK #3 EDUCATIONAL SESSION BLOCK #3A - Hemisfair Ballroom 1&2 Management of Hereditary Risk: Moderate-Risk Genes and New Approaches Moderator: Seema A. Khan, MD Northwestern University Chicago, IL Cancer risks in patients with moderate penetrance gene mutations Payal D. Shah, MD Penn Medicine Philadelphia, PA Screening for high-risk patients: Does everyone need annual MRI with mammogram? Madeleine M.A. Tilanus-Linthorst, MD, PhD Erasmus University Medical Center Rotterdam, Netherlands Hormonal exposure and risk in BRCA1/2 carriers Joanne Kotsopoulos, MSc, PhD University of Toronto Toronto, Canada EDUCATIONAL SESSION BLOCK #3B - Stars at Night Ballroom 1&2 Challenging Types of Breast Cancer Moderator: Bora Lim, MD Baylor College of Medicine Houston, TX Pathologic aspects Jorge S. Reis-Filho, MD, PhD Memorial Sloan Kettering Cancer Center New York, NY Metaplastic Alexandra Thomas, MD, FACP Wake Forest Baptist Health Winston-Salem, NC Inflammatory Filipa Lynce, MD Dana-Farber Cancer Institute Boston, MA Lobular/pleomorphic Sibylle Loibl, MD, PhD German Breast Group Neu-isenburg, Germany EDUCATIONAL SESSION BLOCK #3C - Stars at Night Ballroom 3&4 What ctDNA Can Tell Us Moderator: Nicholas Turner, PhD, FRCP The Royal Marsden Hospital London, United Kingdom Which is the best technique Heather Parsons, MD, MPH Dana-Farber Cancer Institute Boston, MA Can ctDNA substitute tissue testing Ben O'Leary, MBBS, PhD The Institute of Cancer Research London, United Kingdom Using ctDNA in detecting disease Minetta C. Liu, MD Natera Austin, TX
5:00 pm - 6:15 pm CT	POSTER SESSION #5 - Hall 1 SPOTLIGHT POSTER DISCUSSION SESSION #13 Therapeutic Approaches for HR+/Her2- Breast Cancer - Stars at Night Ballroom 1&2 SPOTLIGHT POSTER DISCUSSION SESSION #14 Breast Cancer Risk Modeling - Stars at Night Ballroom 3&4 SPOTLIGHT POSTER DISCUSSION SESSION #15 Local Regional/Management of the Axilla - Hemisfair Ballroom 1&2
	OPEN SATELLITE EVENTS - Marriott Rivercenter
7:00 pm - 8:45 pm	Molecular Imaging and Breast Cancer: Selecting and Evaluating Targeted Treatments presented by Society of Nuclear Medicine and Molecular Imaging
7:15 pm - 9:15 pm	What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of ER-Positive Breast Cancer — An Independent Satellite Symposium Held in Conjunction with the 45th Annual San Antonio Breast Cancer Symposium presented by Research to Practice

Friday, December 9
7:00 am - 8:15 am CT	POSTER SESSION #6 - Hall 1 SPOTLIGHT POSTER DISCUSSION SESSION #16 Imaging to Diagnose Breast Cancer and Direct Its Treatment: Who, When, and How? - Hemisfair Ballroom 1&2 SPOTLIGHT POSTER DISCUSSION SESSION #17 Endocrine Therapy New Insights - Stars at Night Ballroom 1&2 SPOTLIGHT POSTER DISCUSSION SESSION #18 Updates and New Therapies for HER2 Positive Disease - Stars at Night Ballroom 3&4
8:30 am - 9:00 am CT	AACR OUTSTANDING INVESTIGATOR AWARD FOR BREAST CANCER RESEARCH, supported by the Breast Cancer Research Foundation - Hall 3 Breast Cancer Prevention in Premenopausal Women: Accelerating Transition from Discoveries to Clinical Translation Adetunji T. Toriola, MD, PhD, MPH Washington University School of Medicine St. Louis, MO
9:00 AM - 11:30 AM CT	GENERAL SESSION #4 - Hall 3
10:00 am - 5:00 pm CT	EXHIBITS - Hall 2
11:30 am - 12:00 pm CT	BRINKER AWARD FOR SCIENTIFIC DISTINCTION IN CLINICAL RESEARCH The Contribution of NSABP Clinical Trials to the Management of Early Breast Cancer: PAST AS PROLOGUE Norman Wolmark, MD, FACS, FRCSC University of Pittsburgh Pittsburgh, PA
12:00 pm - 3:00 pm CT	GENERAL SESSION #5 - Hall 3
3:00 pm - 5:00 pm CT	EDUCATIONAL SESSION BLOCK #4 EDUCATIONAL SESSION BLOCK #4A - Stars at Night Ballroom 1&2 Advances in Pregnancy Associated Breast Cancer (PABC) Moderator: Kalliopi Siziopikou, MD, PhD Northwestern University Chicago, IL Updates in the pathology of PABCS Kalliopi Siziopikou, MD, PhD Northwestern University Chicago, IL Special treatment issues in this young patient population Ann Partridge, MD, MPH Dana-Farber Cancer Institute Boston, MA Oncofertility and other quality of life issues Matteo Lambertini, MD, PhD University of Genova - San Martino Hospital Genova, Italy EDUCATIONAL SESSION BLOCK #4B - Stars at Night Ballroom 3&4 State of the Art Radiotherapy: Reducing Toxicity and Increasing Options Moderator: Wendy Woodward, MD, PhD UT MD Anderson Cancer Center Houston, TX Overview of the current state of the art - what patients and oncologists need to know Rachel Jimenez, MD Massachusetts General Hospital Boston, MA The role of advanced radiation technology in reducing toxicity Melissa Mitchell, MD, PhD UT MD Anderson Cancer Center Houston, TX Evidence for ablative radiation in metastatic breast cancer Chiaojung Jillian Tsai, MD, PhD Memorial Sloan Kettering Cancer Center New York, NY EDUCATIONAL SESSION BLOCK #4C - Hemisfair Ballroom 1&2 Targeting the Tumor Microenvironment for Clinical Impact Moderator: Diana Cittelly, PhD University of Colorado Anschutz Medical Campus Aurora, CO Influence of bone microenvironment on metastasis Igor Bado, PhD Baylor College of Medicine Houston, TX The contribution of the tumor microenvironment to cancer dormancy J. Javier Bravo-Cordero, PhD Icahn School of Medicine at Mount Sinai New York, NY Effects of age on the tumor microenvironment Sandra S. McAllister, PhD Harvard Institutes of Medicine Boston, MA Can inflammation be targeted? Angela DeMichele, MD, MSCE University of Pennsylvania Philadelphia, PA
5:00 pm - 5:15 pm CT	REFRESHMENT BREAK
5:15 pm - 7:15 pm CT	View from the Trenches: What will You do on Monday Morning - Stars at Night Ballroom 1&2 Moderators: Andrea Barrio, MD, FACS Memorial Sloan Kettering Cancer Center New York, NY and Moderator: Sara Tolaney, MD, MPH Dana-Farber Cancer Institute Boston, MA Panel Members Vernal Branch Patient Advocate UNC Chapel Hill Lineberger Cancer Institute Mooresville, NC Marianna Chavez- MacGregor, MD, MSC, FASCO UT MD Anderson Cancer Center Houston, TX Tanja N. Fehm, MD University Hospital Düsseldorf Düsseldorf, Germany Kalliopi Siziopikou, MD, PhD Northwestern University Chicago, IL Mediget Teshome, MD, MPH, FACS UT MD Anderson Cancer Center Houston, TX Cynthia Villareal Garza, MD, DSc Tecnológico de Monterrey Monterrey, Mexico Richard C. Zellars, MD Indiana University Indianapolis, IN
Saturday, December 10 8:00 am - 10:00 am	YEAR IN REVIEW - Hall 3
	Moderators: Carlos Arteaga, MD UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center Dallas, TX and Virginia G. Kaklamani, MD UT Health San Antonio San Antonio, TX Basic science Andrei Goga, MD, PhD UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, CA Translational research Shom Goel, MBBS, B Med Sci (Hons) Peter MacCallum Cancer Centre Melbourne, Australia Early breast cancer Marleen Kok, MD, PhD Netherlands Cancer Institute Amsterdam, Netherlands Advanced breast cancer Melinda Telli, MD Stanford University School of Medicine San Francisco, CA


12:00 pm - 1:45 pm

Home / 2022 SABCS® / 2022 SABCS Program / Schedule at a Glance

Home / 2022 SABCS^® / 2022 SABCS Program / Schedule at a Glance